ANNA KEATING: Open Payments
NPI 1194407916 · PORT ROYAL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,657 in 63 payments from 20 companies in 2025. Trend: 2023 $162 · 2024 $1,954 · 2025 $1,657
Food & beverage: $1,657
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $233 |
| UCB, Inc. | 5 | $217 |
| ACADIA Pharmaceuticals Inc | 5 | $144 |
| ARGENX US, INC. | 4 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $112 |
| Lundbeck LLC | 4 | $104 |
| Eisai Inc. | 3 | $78 |
| Alexion Pharmaceuticals, Inc. | 3 | $77 |
| Lilly USA, LLC | 3 | $65 |
| Neurocrine BioSciences, Inc. | 3 | $61 |
Products named: Rystiggo, NUPLAZID, Leqembi, VYVGART HYTRULO, QULIPTA, HYQVIA, VYEPTI, ULTOMIRIS.
Industry payments across SC — which companies pay providers there.
